Page 20 - Longeveron Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Longeveron Rights Offering Declared Effective and Calendar Finalized

MIAMI, Aug. 16, 2023 Longeveron Inc. , a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left. -Today at 09:14 am- MarketScreener

United statesMike moyerExchange commissionGlobenewswire incLongeveron or companyRf lafferty co incLongeveron incAging related frailtyRights dayPeriod beginsPeriod endsPrivate securities litigation reform actAnnual reportQuarterly report

Longeveron (LGVN) Rights Offering Declared Effective and Calendar Finalized

Longeveron (LGVN) Rights Offering Declared Effective and Calendar Finalized
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Longeveron or companyLongeveron incExchange commission onExchange commissionRf lafferty co incAging related frailtyRights dayPeriod beginsPeriod endsOkapi partners

Longeveron Rights Offering Declared Effective and Calendar

MIAMI, Aug. 16, 2023 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing.

United statesMike moyerRf lafferty co incExchange commissionExchange commission onLongeveron incLongeveron or companyAging related frailtyRights dayPeriod beginsPeriod endsOkapi partnersPrivate securities litigation reform actAnnual reportQuarterly reportNasdaq lgvn

Longeveron to Host Key Opinion Leader Event on Medicinal Signaling Cells (MSCs) for Hypoplastic Left Heart Syndrome (HLHS) with Lomecel-B™ on August 16, 2023 - Longeveron (NASDAQ:LGVN)

MIAMI, Aug. 14, 2023 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs,

United statesSunjay kaushalVaughna starnesMike moyerRam kumar subramanyanLongeveron lomecelTomr demeesterLos angelesNorthwestern university feinberg school of medicineLongeveron incPhd northwestern university feinberg school of medicineNational institutes of healthWorkforce on national databasesThoracic surgical associationLongeveron coExchange commission on

Longeveron (NASDAQ:LGVN) Issues Quarterly Earnings Results, Misses Expectations By $0 01 EPS

Longeveron (NASDAQ:LGVN – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.01), MarketWatch Earnings reports. Longeveron had a negative return on equity of 87.96% and a negative net margin of 1,765.78%. The firm had revenue of $0.22 million […]

James clavijoLongeveron incGeode capital managementSecurities exchange commissionGamco investorsNorthern trust corpVanguard group incGet free reportMarketwatch earningsExchange commissionTrust corpStreet corpCapital managementLongeveron dailyNasdaq lgvn